Ed Shovelin/LinkedIn
Oct 30, 2026, 17:33
Ed Shovelin: Comparative Hemostatic Performance of CRP-A and Equine Fibrillar Collagen
Ed Shovelin, Operations and Engineering Manager at Pplus Medical Limited, shared a post on LinkedIn about a recent article by Daniele Moine et al., published in RPTH, adding:
“An interesting article is the RPTH Journal comparing CRP-A to equine fibrillar collagen type I-III.”
Title: PB2503 Stability evaluation of a new synthetic Collagen Related Peptide (CRP-A) agonist compared to the equine fibrillar collagen type I-III
Authors: Daniele Moine, Drifa Beroual, Maxime Moulard, Philippe Ohlmann
Find more posts featuring Ed Shovelin on Hemostasis Today.
-
Oct 30, 2026, 17:43Santagata Davide: Can Targeting Inflammation Help Prevent Thrombosis?
-
Oct 30, 2026, 17:38Patrick Ellsworth: Supporting Patients and Families Through Bleeding Disorders Awareness and Community Initiatives
-
Oct 30, 2026, 16:52Tosin Ola: A New Era in Sickle Cell Disease Treatment and the Question of Access
-
Oct 30, 2026, 16:48Cedric Hermans: The Next Generation of FVIIIa-Mimetic Antibodies in Haemophilia A
-
Oct 30, 2026, 16:44Shehab Mohamed: Recognizing Isolated Thrombocytopenia as a Presentation of MDS
-
Oct 30, 2026, 16:40Amrita Sarkar: Advancing the Diagnosis of Anti-PF4 Syndromes
-
Oct 30, 2026, 16:35James Garrard: Driving Innovation in Stroke Care Through Global Collaboration
-
Oct 30, 2026, 16:19Cesar de Almeida Neto: Hemo 2026 Roundtable Focuses on the Challenges of Patient Blood Management
-
Oct 30, 2026, 16:01Marilena Vrana: The Case for Retaining Immunoglobulins on the EU Critical Medicines List